ATM gRNA (BRDN0001149033) Citations (2)

Originally described in: Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9.
Doench JG, Fusi N, Sullender M, Hegde M, Vaimberg EW, Donovan KF, Smith I, Tothova Z, Wilen C, Orchard R, Virgin HW, Listgarten J, Root DE Nat Biotechnol. 2016 Jan 18. doi: 10.1038/nbt.3437. PubMed Journal

---

Articles Citing ATM gRNA (BRDN0001149033)

Articles
Combined DNA Damage Repair Interference and Ion Beam Therapy: Development, Benchmark, and Clinical Implications of a Mechanistic Biological Model. Liew H, Meister S, Mein S, Tessonnier T, Kopp B, Held T, Haberer T, Abdollahi A, Debus J, Dokic I, Mairani A. Int J Radiat Oncol Biol Phys. 2022 Mar 1;112(3):802-817. doi: 10.1016/j.ijrobp.2021.09.048. Epub 2021 Oct 25. PubMed
ATM inhibition exploits checkpoint defects and ATM-dependent double strand break repair in TP53-mutant glioblastoma. Laverty DJ, Gupta SK, Bradshaw GA, Hunter AS, Carlson BL, Calmo NM, Chen J, Tian S, Sarkaria JN, Nagel ZD. Nat Commun. 2024 Jun 21;15(1):5294. doi: 10.1038/s41467-024-49316-8. PubMed

If you have published an article using this material, please email us at to have your article added to this page.